BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2009995)

  • 1. Luteinizing hormone responses to gonadotropin-releasing hormone and naloxone in menstruating women with type I diabetes of different duration.
    Coiro V; Volpi R; Capretti L; Speroni G; Castelli A; Chiodera P
    Fertil Steril; 1991 Apr; 55(4):712-6. PubMed ID: 2009995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery.
    García-Rubí E; Vazquez-Alemán D; Mendez JP; Salinas JL; Garza-Flores J; Ponce-de-León S; Perez-Palacios G; Ulloa-Aguirre A
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):520-8. PubMed ID: 1286522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of residual insulin secretion and duration of diabetes mellitus on the control of luteinizing hormone secretion in women.
    Volpi R; Chiodera P; Gramellini D; Capretti L; Caffarri G; Speroni G; Vescovi PP; Coiro V
    Eur J Clin Invest; 1998 Oct; 28(10):819-25. PubMed ID: 9792995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonist of gonadotropin-releasing hormone blocks naloxone-induced elevations in serum luteinizing hormone.
    Blank MS; Roberts DL
    Neuroendocrinology; 1982 Nov; 35(5):309-12. PubMed ID: 6755289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poorly controlled type I diabetes mellitus in young men selectively suppresses luteinizing hormone secretory burst mass.
    López-Alvarenga JC; Zariñán T; Olivares A; González-Barranco J; Veldhuis JD; Ulloa-Aguirre A
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5507-15. PubMed ID: 12466346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis.
    Lanfranco F; Bonelli L; Baldi M; Me E; Broglio F; Ghigo E
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3633-9. PubMed ID: 18559917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus.
    Djursing H; Hagen C; Nyholm HC; Carstensen L; Andersen AN
    J Clin Endocrinol Metab; 1983 May; 56(5):1016-21. PubMed ID: 6403566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory patterns and rates of gonadotropin-releasing hormone, follicle-stimulating hormone, and luteinizing hormone revealed by intensive sampling of pituitary venous blood in the luteal phase mare.
    Irvine CH; Alexander SL
    Endocrinology; 1993 Jan; 132(1):212-8. PubMed ID: 8419124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of estradiol infusion and naloxone on luteinizing hormone secretion in pubertal boys.
    Kletter GB; Padmanabhan V; Beitins IZ; Marshall JC; Kelch RP; Foster CM
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4010-4. PubMed ID: 9398704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and late hormonal responses to the microdose gonadotropin-releasing hormone agonist in normal menstruating women.
    Park WI; Kim SS; Chung HR; Shin SY; Lee JY
    Fertil Steril; 2004 Apr; 81(4):1067-72. PubMed ID: 15066465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic inhibition of pulsatile luteinizing hormone secretion is abnormal in regularly menstruating women with insulin-dependent diabetes mellitus.
    Grodum E; Hangaard J; Christensen L; Haug E; Hagen C
    Fertil Steril; 1995 Aug; 64(2):279-84. PubMed ID: 7615103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women.
    Cagnacci A; Melis GB; Paoletti AM; Soldani R; Fioretti P
    J Clin Endocrinol Metab; 1990 Feb; 70(2):365-70. PubMed ID: 2105330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
    Barbarino A; De Marinis L; Tofani A; Della Casa S; D'Amico C; Mancini A; Corsello SM; Sciuto R; Barini A
    J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of naloxone on GnRH-induced LH and FSH release in buffalo, Bubalus bubalis.
    Palta P; Chandrasekhar T; Prakash BS; Madan ML
    Indian J Exp Biol; 2000 Apr; 38(4):390-2. PubMed ID: 11218818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing hormone and cortisol responses to naloxone in normal weight women with bulimia.
    Coiro V; d'Amato L; Marchesi C; Capretti L; Volpi R; Roberti G; Cerri L; Chiodera P
    Psychoneuroendocrinology; 1990; 15(5-6):463-70. PubMed ID: 2101966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-specific pituitary responses in insulin-dependent diabetes mellitus in children and adolescents].
    Iughetti L; Petraglia F; Facchinetti F; Genazzani AR; Cozzini A; Vanelli M; Bernasconi S
    Presse Med; 1995 Dec 16-23; 24(39):1894-8. PubMed ID: 8745537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteinizing hormone releasing hormone mediates naloxone's effects on serum luteinizing hormone levels in normal and morphine-sensitized male rats.
    Cicero TJ; Schmoeker PF; Meyer ER; Miller BT
    Life Sci; 1985 Aug; 37(5):467-74. PubMed ID: 3894852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.